Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 265720

The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome


Degoricija, Vesna; Sharma, Mirella; Legac, Ante; Gradišer, Marina; Šefer, Siniša; Vučičević, Željko
The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome // Intensive Care Medicine / European Society of Intensive Care Medicine (ur.).
Barcelona: Springer, 2006. str. S 20-S 20 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 265720 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome

Autori
Degoricija, Vesna ; Sharma, Mirella ; Legac, Ante ; Gradišer, Marina ; Šefer, Siniša ; Vučičević, Željko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Intensive Care Medicine / European Society of Intensive Care Medicine - Barcelona : Springer, 2006, S 20-S 20

Skup
19th Annual Congress of European Society of Intensive Care Medicine

Mjesto i datum
Barcelona, Španjolska, 24.09.2006. - 27.09.2006

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
sepsis; intensive care unit; performane; antimicrobial therapy; outcome

Sažetak
Introduction. Paper evaluated epidemiology of sepsis in medical intensive care unit (ICU), and the impact of ICU performance and adequate empirical antibiotic therapy on survival. Methods. Observational, prospective study assessed all patients (pts) meeting criteria for sepsis at admission. Clinical presentation of sepsis was defined according to 2001 International sepsis definitions conference. Demographic and epidemiology data, severity of sepsis, ICU/hospital stay, outcome, performance and appropriateness of empirical antibiotic therapy were analyzed. Results. The study included 314 (6.3%) pts, predominantly male, median age 71, 176 (56.1%) ICU survivors and 138 (43.9%) non-survivors. The non-survivors were older, with limited mobility and predominantly male (p<0.001 ; p<0.001 ; p=0.030). There were more septic pts in the winter (p=0.013) with higher death rate (p=0.002). Mean length of stay was 6.97 days for ICU, and 15.82 days for hospital. Non-survivors had significantly lower GCS and higher APACHE II and SOFA scores (p<0.001 for all), and history of chronic heart (p<0.001), and respiratory (p<0.001) failure. At the ICU admission sepsis was present in 100 (31.8%), severe sepsis in 89 (28.6%), and septic shock in 125 (39.8%) pts with mortality rates 17%, 33.7%, 72.1% respectively. 244 (77.7%) pts developed at least one organ dysfunction syndrome, out of 138 (43.9%) pts who met criteria for septic shock, 107 (75.4) were non-survivors (p<0.001). Microbiological documentation of sepsis was obtained in 235 (74.8%) pts ; bloodstream infection was documented in 62 (19.8%), urinary in 65 (20.7%), and respiratory tract infection in 16 (5.1%) pts ; 86 (27.4%) had documented infection in bloodstream and focus, and 6 (1.9%) in two different focuses. Positive blood culture rate at admission was 49%, documented presence of bacteria in bloodstream was related to better outcome (p<0.001). Urinary tract infections were the most common 168 (53.5%), followed by skin/soft tissue 58 (18.5%), lower respiratory tract 44 (14.0%) and gallbladder/bile ducts 17 (5.4%) infections. Lower respiratory tract as focus of sepsis was connected with worse outcome (p<0.001). Empirical antibiotic treatment was considered adequate in 106 (60.5%) survivors and 42 (31.2%) non-survivors, and inadequate in 70 (39.5%) survivors and 96 (68.8%) non-survivors (p=<0.001). Patients treated with adequate empirical antibiotic therapy had significantly higher survival time in hospital (log-rank p=0.0011). Conclusion. Sepsis syndrome commonly occurs among vulnerable pts, such as elderly and pts with multiple comorbidities. ICU management and performance with aggressive resuscitation of septic pts, and prompt and appropriate empiric antimicrobial treatment is life saving. Severity of illness of this group of pts was underestimated in emergency department, which resulted in time delay in ICU admission that might be fatal.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"

Profili:

Avatar Url Željko Vučičević (autor)

Avatar Url Vesna Degoricija (autor)


Citiraj ovu publikaciju:

Degoricija, Vesna; Sharma, Mirella; Legac, Ante; Gradišer, Marina; Šefer, Siniša; Vučičević, Željko
The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome // Intensive Care Medicine / European Society of Intensive Care Medicine (ur.).
Barcelona: Springer, 2006. str. S 20-S 20 (poster, međunarodna recenzija, sažetak, znanstveni)
Degoricija, V., Sharma, M., Legac, A., Gradišer, M., Šefer, S. & Vučičević, Ž. (2006) The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome. U: European Society of Intensive Care Medicine (ur.)Intensive Care Medicine.
@article{article, author = {Degoricija, Vesna and Sharma, Mirella and Legac, Ante and Gradi\v{s}er, Marina and \v{S}efer, Sini\v{s}a and Vu\v{c}i\v{c}evi\'{c}, \v{Z}eljko}, year = {2006}, pages = {S 20-S 20}, keywords = {sepsis, intensive care unit, performane, antimicrobial therapy, outcome}, title = {The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome}, keyword = {sepsis, intensive care unit, performane, antimicrobial therapy, outcome}, publisher = {Springer}, publisherplace = {Barcelona, \v{S}panjolska} }
@article{article, author = {Degoricija, Vesna and Sharma, Mirella and Legac, Ante and Gradi\v{s}er, Marina and \v{S}efer, Sini\v{s}a and Vu\v{c}i\v{c}evi\'{c}, \v{Z}eljko}, year = {2006}, pages = {S 20-S 20}, keywords = {sepsis, intensive care unit, performane, antimicrobial therapy, outcome}, title = {The impact of ICU performance and empirical antimicrobial therapy on sepsis outcome}, keyword = {sepsis, intensive care unit, performane, antimicrobial therapy, outcome}, publisher = {Springer}, publisherplace = {Barcelona, \v{S}panjolska} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font